文献速递前列腺癌

限制谱成像磁共振提升主动监测前列腺癌活检升级检测

Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance.
PubMed 文献 · J Urol · 2021-02-22

这项前瞻性研究纳入2016年1月至2019年6月接受重复活检的主动监测男性,评估限制谱成像磁共振(RSI-MRI)预测Gleason升级的效用。结果显示RSI生成的受限信号图值>50时,敏感度、特异度、阳性预测值和阴性预测值分别为81.0%、81.8%、54.2%和94.2%,优于PI-RADS≥3的相应值,并将AUC从0.70提升至0.90。结论认为RSI-MRI可作为无创放射学生物标志物辅助标准PI-RADS系统预测升级。

要点

  • RSI-MRI受限信号图值>50预测Gleason升级的敏感度81.0%、特异度81.8%。
  • RSI-MRI将预测升级的AUC从0.70(95%CI 0.49-0.92)提升至0.90(95%CI 0.82-0.98)。
  • RSI-MRI可作为无创放射学生物标志物增强标准PI-RADS系统。

核心结论

  • RSI-MRI通过提供无创放射学生物标志物,增强标准PI-RADS系统预测主动监测患者的Gleason升级。

研究设计与样本

  • 前瞻性队列研究,2016年1月至2019年6月纳入123名接受重复活检的主动监测男性,110名受试者中识别74个RSI-MRI感兴趣区,105名完成活检。

主要发现

  • 受限信号图按PI-RADS评分对真阳性病灶检测显著(平均差28,SD 0.7,p=0.001),优于表观扩散系数(平均差-15,SD 55,p=0.6)。
  • 受限信号图值>50预测Gleason升级的敏感度81.0%、特异度81.8%、阳性预测值54.2%、阴性预测值94.2%。
  • PI-RADS≥3预测Gleason升级的敏感度71.4%、特异度38.9%、阳性预测值23.7%、阴性预测值83.7%。
  • RSI-MRI将预测升级的AUC从0.70(95%CI 0.49-0.92,p=0.03)提升至0.90(95%CI 0.82-0.98,p<0.001)。

临床怎么用

  • 在主动监测患者的重复活检决策中,可参考RSI-MRI受限信号图值>50辅助预测Gleason升级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Restriction spectrum imaging-magnetic resonance imaging is a short duration enhanced diffusion-weighted technique that seeks to standardize sequences and predict upgrading. We test this technology for active surveillance biopsies. Our objective is to investigate the utility of restriction spectrum imaging-magnetic resonance imaging to improve upgrading detection in a prostate cancer active surveillance cohort. MATERIALS AND METHODS: We prospectively enrolled men on active surveillance undergoing repeat biopsy from January 2016 to June 2019. Subjects underwent prostate multiparametric magnetic resonance imaging and restriction spectrum imaging-magnetic resonance imaging reviewed by a urological radiologist for PI-RADS® scored lesions, followed by magnetic resonance imaging-guided prostate biopsy by a urologist. Restriction spectrum imaging-magnetic resonance imaging analysis with proprietary research software (CorTechs Labs, San Diego, California) generated a restricted signal map. We compared the restricted signal map and apparent diffusion coefficient values using T-test, ANOVA, and logistic regression analyses for prediction of upgrading. RESULTS: Of 123 enrolled men we identified 74 restriction spectrum imaging-magnetic resonance imaging regions of interest (targeted lesions) in 110 subjects, with 105 subjects completing biopsy. The restricted signal map was significant per PI-RADS score for true-positive lesion detection (mean difference 28, SD 0.7, p=0.001), and better than apparent diffusion coefficient (mean difference -15, SD 55, p=0.6). Restriction spectrum imaging generated restricted signal map values >50 improved sensitivity, specificity, positive predictive value and negative predictive value (81.0%, 81.8%, 54.2% and 94.2%) over PI-RADS ≥3 (71.4%, 38.9%, 23.7% and 83.7%, respectively) for Gleason upgrading. Overall restriction spectrum imaging is able to improve the AUC of 0.70 (95% CI 0.49-0.92, p=0.03) to 0.90 (95% CI 0.82-0.98, p <0.001). CONCLUSIONS: Restriction spectrum imaging-magnetic resonance imaging enhances the standard PI-RADS system by providing a noninvasive radiological biomarker to predict upgrading in active surveillance.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Besasie BD, Sunnapwar AG, Gao F, et al. Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance. J Urol. 2021. PMID: 33617334. doi:10.1097/JU.0000000000001692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。